INDEMNIFICATION AGREEMENTIndemnification Agreement • March 17th, 2010 • Chay Enterprises, Inc. • Real estate • Delaware
This Indemnification Agreement (“Agreement”) is effective as of , 2010, by and between Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Company” or “Ampio”), and (Name) (“Indemnitee”).
RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • March 17th, 2010 • Chay Enterprises, Inc. • Real estate • Colorado
THIS RESTRICTED STOCK AGREEMENT (this “Agreement”) is made effective as of April 17, 2009 (the “Grant Date”), by and between DMI Life Sciences, Inc., a Delaware corporation (the “Company”), and Bruce G. Miller (the “Holder”):
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 17th, 2010 • Chay Enterprises, Inc. • Real estate
This Exclusive License Agreement (“Agreement”) effective as of February 17, 2009 (the “Effective Date”) is by and between DMI BioSciences, Inc., a Colorado corporation having its principal place of business at 8400 East Crescent Parkway, Suite 600, Greenwood Village, Colorado 80111 (“DMI”), and Institute For Molecular Medicine, Inc., a non-profit corporation organized and existing under the laws of Colorado, having a place of business at 3531 South Logan Street, Suite D318, Englewood, Colorado 80110 (“IMM”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 17th, 2010 • Chay Enterprises, Inc. • Real estate • Colorado
This Employment Agreement (the “Agreement”), is effective as of April 17, 2009 (the “Effective Date”), between DMI LIFE SCIENCES, INC., a Delaware corporation (with its successors and assigns, referred to as the “Company”), and DAVID BAR-OR, M.D. (“Employee”).
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • March 17th, 2010 • Chay Enterprises, Inc. • Real estate • Colorado
This Sponsored Research Agreement (the “Agreement”) is made by and between Trauma Research LLC (“TRLLC”), a Colorado limited liability company, having its address at 900 East Oxford Lane, Englewood, Colorado 80113 and DMI Life Sciences, Inc. (“Sponsor”), a Delaware corporation, with its principal place of business at 8400 East Crescent Parkway, Suite 600, Greenwood Village, Colorado 80111.
FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 17th, 2010 • Chay Enterprises, Inc. • Real estate • Colorado
This First Amendment To Exclusive License Agreement (“First Amendment”), effective as of April 17, 2009 (the “First Amendment Effective Date”), is by and between DMI Life Sciences, Inc., a Delaware corporation having its principal place of business at 8400 East Crescent Parkway, Suite 600, Greenwood Village, Colorado 80111 (“DMI”), and Institute For Molecular Medicine, Inc., a non-profit corporation organized and existing under the laws of Colorado, having a place of business at 3531 South Logan Street, Suite D318, Englewood, Colorado 80110 (“IMM”).
INVESTOR RELATIONS CONSULTING AGREEMENTInvestor Relations Consulting Agreement • March 17th, 2010 • Chay Enterprises, Inc. • Real estate • California
This Consulting Agreement (the “Agreement”) effective as of March 2, 2010 is entered into by and between Ampio Pharmaceuticals Inc, formerly referred to as DMI Life Sciences, Inc., a Colorado corporation (herein referred to as the “Company”) and Redwood Consultants, LLC, a California Limited Liability Company (herein referred to as “RC” or the “Redwood”) or it’s successors, designees or assignees, and replaces and supercedes any and all other agreements between the above parties.
AT-WILL EMPLOYMENT, CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT, AND ARBITRATION AGREEMENTAt-Will Employment Agreement • March 17th, 2010 • Chay Enterprises, Inc. • Real estate
As a condition of my employment with DMI Life Sciences, Inc., its subsidiaries, affiliates, successors or assigns (together, the “Company”), and in consideration of my employment with the Company and my receipt of the compensation now and hereafter paid to me by Company, I agree to the following provisions of this DMI Life Sciences, Inc. At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement (this “Agreement”):
